Bo Wei

7PUBLICATIONS
54CO-AUTHORS
Proteomics and metabolomicsReaction engineering (excl. nuclear reactions)Molecular targetsInstrumental methods (excl. immunological and bioassay methods)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 09, 2026
High-throughput multi-organ proteomics workflow for drug efficacy and toxicity analysis.

Yun Xiong, Lin Tan, Wai-Kin Chan

|Jan 30, 2026
Supercharging-enhanced nDIA-MS enables global profiling of drug-induced proteome solubility shifts.

Yun Xiong, Huimin Zhang, Lin Tan

|May 13, 2025
CHD1 loss reprograms SREBP2-driven cholesterol synthesis to fuel androgen-responsive growth and castration resistance in SPOP-mutated prostate tumors.

Feiyu Chen, Haoyan Li, Yin Wang

|Feb 05, 2025
Ion suppression correction and normalization for non-targeted metabolomics.

Iqbal Mahmud, Bo Wei, Lucas Veillon

|Oct 11, 2024
Imipridones inhibit tumor growth and improve survival in an orthotopic liver metastasis mouse model of human uveal melanoma.

Chandrani Chattopadhyay, Janos Roszik, Rajat Bhattacharya

|Sep 27, 2024
Inhibition of hepatic oxalate overproduction ameliorates metabolic dysfunction-associated steatohepatitis.

Sandeep Das, Alexandra C Finney, Sumit Kumar Anand

Pageof 2

Frequent Collaborators

7 joint publications

Philip L Lorenzi

4 joint publications

Iqbal Mahmud

3 joint publications

John N Weinstein

2 joint publications

Rehan Akbani